Search Results - "Ananthula, Ravi Shekar"

Quantification and In Silico Toxicity Assessment of Tazarotene and its Impurities for a Quality and Safe Drug Product Development by Nagulakonda, NVVSS Narayana Murty, Ananthula, Ravi Shekar, Krishnamurthy, T, Rao, Muguda Ravi Prasada, Rao, Gollapalli Nageswara

“…Abstract Tazarotene is internationally accepted common name for ethyl 6-[(4,4-dimethylthiochroman-6-yl)ethynyl]nicotinate. It is a synthetic retinoid used for…”
Get full text

Quantification and In Silico Toxicity Assessment of Nimesulide and its Related Substances by Nagulakonda, NVVSS Narayana Murty, Ananthula, Ravi Shekar, Susarla, Krishna Phani Chandra, Krishnamurthy, T., Gollapalli, Nageswara Rao

“…Abstract Availability of analytical method which is compatible with both Ultra high performance liquid chromatography (UHPLC) and Liquid chromatography mass…”
Get full text

Insights from ligand and structure based methods in virtual screening of selective Ni-peptide deformylase inhibitors by Ananthula, Ravi Shekar, Ravikumar, Muttineni, Mahmood, S. K., Kumar, M. N. S. Pavan

“…In recent years, there has been a growing interest in developing bacterial peptide deformylase (PDF) inhibitors as novel antibiotics. The purpose of the study…”
Get full text

Strategies for generating less toxic P-selectin inhibitors: Pharmacophore modeling, virtual screening and counter pharmacophore screening to remove toxic hits by Ananthula, Ravi Shekar, Ravikumar, Muttineni, Pramod, A.B., Madala, Kishore Kumar, Mahmood, S.K.

“…This paper describes the generation of ligand-based as well as structure-based models and virtual screening of less toxic P-selectin receptor inhibitors…”
Get full text